Searchable abstracts of presentations at key conferences in endocrinology

ea0073oc15.3 | Oral Communications 15: Late Breaking | ECE2021

Targeting PI3K and CDKs as effective therapeutic option for PPGLs in vitro and in vivo

Gulde Sebastian , Martino Daniela De , Mohr Hermine , Satam Swapna , Foscarini Alessia , Nölting Svenja , Pellegata Svenja

Pheochromocytoma and Paraganglioma, collectively referred to as PPGLs, are rare, mostly benign neuroendocrine tumors arising from chromaffin cells of the adrenal gland or of extra-adrenal sites, respectively. Surgery is the first-line therapy for localized PPGLs. However, up to 17% of PPGLs show metastatic spread, and for these cases there is no curative treatment. Therefore, the identification of novel therapeutic approaches for advanced PPGLs is highly clinically relevant. W...